U

Sade Group

Cannabis-based Pharmaceutical Products
Startup Seed Founded 2015 Health Tech & Life Sciences
Last Update Jun 12, 2023

Sade Group News

2 articles
Jul 7, 2019 · en.globes.co.il
growth-negative
Ori Yehudai quits cannabis co Sade after two months
Ori Yehudai, former CEO of Frutarom, has stepped down as executive chairman of Sadé Group, a cannabis company. Yehudai joined Sadé in May and it is unclear if his resignation will involve the withdrawal of his investment in the company. Yehudai has expressed his belief in the long-term potential of the cannabis industry, but also acknowledges the need for time and resources to build a genuine company. He has previously spoken about the importance of building global companies in Israeli industry.
Management Changes
May 16, 2019 · www.prnewswire.com
growth-positive
After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor
Former Frutarom CEO Ori Yehudai is joining the cannabis company Sade Group as an active chairman and investor. The company, which covers the entire process from seed to cannabis-based pharmaceutical products, aims to become one of the leading medicinal cannabis companies. With the support of investors Yakir Gabay and Ran Nussbaum, Sade Group plans to raise significant funds to expand into new acquisitions and enter markets in Europe and other regions. The company also intends to develop unique strains based on clinical research and establish recognized brands in the fields of medicine, food, and cosmetics.
InvestmentExpand